Mitsubishi UFJ Trust & Banking’s Juno Therapeutics, Inc. JUNO Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-879,560	Closed	-$40.2M	–	825
2017 Q4	$40.2M	Sell	879,560 -18,480	-2%	-$922K	0.07%	315
2017 Q3	$40.3M	Sell	898,040 -3,710	-0.4%	-$126K	0.07%	305
2017 Q2	$27M	Sell	901,750 -22,900	-2%	-$565K	0.05%	412
2017 Q1	$20.5M	Sell	924,650 -23,670	-2%	-$508K	0.04%	483
2016 Q4	$17.9M	Sell	948,320 -72,680	-7%	-$1.78M	0.04%	509
2016 Q3	$30.6M	Buy	1,021,000 +61,770	+6%	+$1.92M	0.06%	348
2016 Q2	$36.9M	Sell	959,230 -32,450	-3%	-$1.35M	0.08%	288
2016 Q1	$37.8M	Buy	+991,680	New	+$34.6M	0.08%	275

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Mitsubishi UFJ Trust & Banking's JUNO Position: Q1 2018 in Review

Mitsubishi UFJ Trust & Banking sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 879,560 shares — an estimated $40.2M sold.

Mitsubishi UFJ Trust & Banking first reported a position in JUNO in Q1 2016 and held it in 8 quarters. The position peaked at $40.3M in Q3 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Mitsubishi UFJ Trust & Banking reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Mitsubishi UFJ Trust & Banking sold 879,560 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $40.2M.
Mitsubishi UFJ Trust & Banking first reported a position in Juno Therapeutics, Inc. in Q1 2016 and held it in 8 quarters.
Mitsubishi UFJ Trust & Banking's Juno Therapeutics, Inc. position peaked at $40.3M in Q3 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q1 2018, filed 11 May 2018.